Treatment
Albendazole clinical trials
We’re tracking 6 recruiting studies that include Albendazole, each written for real people, not researchers, below.
Recruiting studies
- NCT04713787RecruitingPhase 2
Test higher doses of oxfendazole against single-dose albendazole
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
Santa Clara, MaynasAges 18–65 - NCT07707817Recruiting
Expanding preventive medicine access for mobile groups
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
Ondo, Ondo, Taraba and Akwa IbomAges 5 years+ - NCT06265870Recruiting
Targeted vs. General Antiparasitic Treatment for High Eosinophils
This study compares a specific antiparasitic treatment to a general one for people with high eosinophil levels (a type of white blood cell). If you have eosinophilia without an obvious cause, you may be assigned to receive either a targeted drug or a broader treatment to see which works better.
Hat Yai, Changwat SongkhlaAges 18 years+ - NCT07074444RecruitingPhase 4
Treating clonorchiasis with three different drugs
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
Nanning, GuangxiAges 18 years+ - NCT07045493Enrolling by invitationPhase 2
Combination therapy for soil-transmitted worms in children aged 2-5
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
DhakaAges 2–5 - NCT06282315RecruitingPhase 3
Safety of a new deworming pill for children in Ghana and Kenya
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
Accra, AccraAges 5–17
What Albendazole is being studied for
Conditions with recruiting Albendazole studies.
Common questions
- Are there clinical trials studying Albendazole?
- Yes. Clin2 currently lists 6 recruiting studies that include Albendazole, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Albendazole trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Albendazole an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Albendazole or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.